Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Chuikyo Subcommittee to Form Consensus on Drug Prices by Autumn
March 26, 2001
- Mucosal Influenza Vaccine More Effective than Conventional Vaccines
March 26, 2001
- Mochida to Restructure Its Production System
March 26, 2001
- Chuikyo Subcommittee Starts Discussions for Next Revision of Medical Fees
March 26, 2001
- Draft Guidelines on Genetic Testing Compiled by Eight Societies
March 26, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF
March 26, 2001
- 850 Questions Received Regarding Evidence for Off-label Use of Drugs
March 26, 2001
- Gene Therapy for Buerger's Disease to Be Approved Shortly
March 26, 2001
- Applications Aimed at Preventing Accidents to Be Approved Quickly
March 26, 2001
- DIAGNOSTIC NEWS IN BRIEF
March 26, 2001
- LDP Convention Calls For Radical Reform in 2002
March 26, 2001
- MEDICAL DEVICE NEWS IN BRIEF
March 26, 2001
- DPJ Starts Discussions on Healthcare Reform
March 26, 2001
- OTC NEWS IN BRIEF
March 26, 2001
- Medical Institution Information System to Go into Operation in Osaka
March 26, 2001
- Kemporen Members' Ordinary Loss to Increase to \490.4 Bil.
March 26, 2001
- PMSB to Publish Criteria for Disclosure or Non-disclosure of Information
March 26, 2001
- Aiming at \30 Billion Sales in 2005: Mr Strenger of Aventis Behring
March 26, 2001
- More Patents Exported than Imported in Pharmaceutical Field
March 26, 2001
- Roche's Herceptin Marks Step toward Tailor-made Medicine
March 26, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…